documents: FDA-2009-P-0595-0006

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2009-P-0595-0006 FDA FDA-2009-P-0595 Attachment A - "Advisory Committee Briefing Document for Meridia (Sibutramine HydrochloridemMonohydrate) Endocrinologic and Metabolic Drug Advisory Committee Meeting on September 15, 2010" - [Abbott Laboratories, Inc. - Comment] Supporting & Related Material C-Comment (Supporting and Related Material) 2011-01-28T05:00:00Z 2011 1     2011-01-28T21:20:58Z   0 0 0900006480b61f7a

Links from other tables